Technology

Capricor

$5.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (+2.67%) Today
-$0.06 (-1.11%) As of 9:52 PM UTC after-hours

Why Robinhood?

You can buy or sell Capricor and other stocks, options, and ETFs commission-free!

About CAPR

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. The listed name for CAPR is Capricor Therapeutics, Inc. Common Stock.

CEO
Linda Marbán
Employees
16
Headquarters
Beverly Hills, California
Founded
2005
Market Cap
101.10M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.02M
High Today
$5.47
Low Today
$4.97
Open Price
$5.25
Volume
663.53K
52 Week High
$12.32
52 Week Low
$0.88

Collections

CAPR Earnings

-$0.70
-$0.47
-$0.23
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 17, After Hours

You May Also Like

PVH
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure